Skip to search.
 TSX Down 0.80% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS

22.58 Jun 19, 4:00PM EDT

Add to Portfolio
Prev Close:22.58
Open:N/A
Bid:15.61 x 100
Ask:25.00 x 500
1y Target Est:19.71
Beta:1.65
Next Earnings Date: 7-Aug-13ISIS Earnings announcement
Day's Range:N/A - N/A
52wk Range:7.56 - 24.04
Volume:0
Avg Vol (3m):1,509,010
Market Cap:2.34B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISIS 0.00%2.34B
NVO 0.00%85.98B
TEVA 0.00%33.48B
AGN 0.00%29.43B
FRX 0.00%11.16B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.71
Quarterly EPS Est (Jun-13) :-0.22
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-1.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product, KYNAMRO injection, is an apo-B synthesis inhibitor for patients with homozygous famili... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback